Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
17575 | 529 | 51.0 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MARC RUTI BELL VASC BIOL DIS PROGRAM | Address | 8 | 34% | 4% | 20 |
2 | MIR 33 | Author keyword | 5 | 50% | 1% | 7 |
3 | ABCA1 PROTEIN | Author keyword | 4 | 75% | 1% | 3 |
4 | SPATA2 | Author keyword | 4 | 75% | 1% | 3 |
5 | PHARMACOPROTE HUNAN PROV | Address | 3 | 100% | 1% | 3 |
6 | INTEGRAT CELL SIGNALING NEUROBIOL METAB PROGRAM | Address | 3 | 45% | 1% | 5 |
7 | CHILDREN HLTH CARE | Address | 3 | 35% | 1% | 7 |
8 | ISLET CELL EXOCYTOSIS | Address | 2 | 67% | 0% | 2 |
9 | MARC RUTI BELL VASC BIOL DIS PROGRAM MED | Address | 2 | 67% | 0% | 2 |
10 | MIR 27 | Author keyword | 2 | 40% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MIR 33 | 5 | 50% | 1% | 7 | Search MIR+33 | Search MIR+33 |
2 | ABCA1 PROTEIN | 4 | 75% | 1% | 3 | Search ABCA1+PROTEIN | Search ABCA1+PROTEIN |
3 | SPATA2 | 4 | 75% | 1% | 3 | Search SPATA2 | Search SPATA2 |
4 | MIR 27 | 2 | 40% | 1% | 4 | Search MIR+27 | Search MIR+27 |
5 | MIR 375 | 2 | 18% | 2% | 10 | Search MIR+375 | Search MIR+375 |
6 | MICRORNA 26B | 2 | 43% | 1% | 3 | Search MICRORNA+26B | Search MICRORNA+26B |
7 | LNA ANTIMIR | 1 | 50% | 0% | 2 | Search LNA+ANTIMIR | Search LNA+ANTIMIR |
8 | MICRORNA 33 | 1 | 50% | 0% | 2 | Search MICRORNA+33 | Search MICRORNA+33 |
9 | MICRORNA 467B | 1 | 100% | 0% | 2 | Search MICRORNA+467B | Search MICRORNA+467B |
10 | MICRORNA 613 | 1 | 100% | 0% | 2 | Search MICRORNA+613 | Search MICRORNA+613 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SPONTANEOUS RAT MODEL | 34 | 93% | 2% | 13 |
2 | MIR 33 | 27 | 66% | 5% | 25 |
3 | INSULIN TARGET TISSUES | 11 | 78% | 1% | 7 |
4 | SUBCUTANEOUS ADIPOSE | 10 | 52% | 3% | 14 |
5 | EXPRESSION CONTRIBUTE | 6 | 80% | 1% | 4 |
6 | IMPAIRS GLUCOSE METABOLISM | 4 | 47% | 1% | 7 |
7 | MIR 30 FAMILY | 4 | 67% | 1% | 4 |
8 | INHIBITS ADIPOGENIC DIFFERENTIATION | 3 | 50% | 1% | 4 |
9 | MICRORNA EXPRESSION CONTRIBUTE | 3 | 60% | 1% | 3 |
10 | RAISES PLASMA HDL | 2 | 67% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of islet microRNAs in diabetes: which model for which question? | 2015 | 2 | 43 | 70% |
MicroRNAs in metabolism and metabolic disorders | 2012 | 209 | 143 | 35% |
MicroRNA regulatory networks in human adipose tissue and obesity | 2015 | 3 | 152 | 39% |
MicroRNAs: Emerging roles in adipogenesis and obesity | 2014 | 13 | 93 | 49% |
microRNAs in the onset and development of cardiovascular disease | 2014 | 17 | 108 | 26% |
MicroRNAs and Metabolism Crosstalk in Energy Homeostasis | 2013 | 25 | 96 | 44% |
MicroRNAs and Type 2 Diabetes/Obesity | 2012 | 26 | 84 | 68% |
Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications | 2015 | 1 | 89 | 37% |
Application of microRNAs in diabetes mellitus | 2014 | 4 | 75 | 59% |
MicroRNA-33a/b in Lipid Metabolism - Novel "Thrifty" Models | 2015 | 1 | 46 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MARC RUTI BELL VASC BIOL DIS PROGRAM | 8 | 34% | 3.8% | 20 |
2 | PHARMACOPROTE HUNAN PROV | 3 | 100% | 0.6% | 3 |
3 | INTEGRAT CELL SIGNALING NEUROBIOL METAB PROGRAM | 3 | 45% | 0.9% | 5 |
4 | CHILDREN HLTH CARE | 3 | 35% | 1.3% | 7 |
5 | ISLET CELL EXOCYTOSIS | 2 | 67% | 0.4% | 2 |
6 | MARC RUTI BELL VASC BIOL DIS PROGRAM MED | 2 | 67% | 0.4% | 2 |
7 | GENOME IL CORE SERV | 1 | 100% | 0.4% | 2 |
8 | WORLD PREMIR INT INITIAT WPI | 1 | 100% | 0.4% | 2 |
9 | AGING DIABET TEAM | 1 | 40% | 0.4% | 2 |
10 | CHANNELOPATHY | 1 | 40% | 0.4% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000244606 | RNA CARDIOVASC//IMTTS//MIR 133 |
2 | 0.0000223146 | MIR 140//MICRORNA 140//MICRORNA TARGET IDENTIFICATION |
3 | 0.0000194378 | MIR 122//MICRORNA 122//MIR 224 |
4 | 0.0000179045 | GW182//DROSHA//ARGONAUTE |
5 | 0.0000174373 | MOL DIABET//GDD GED TOXICOL//HARVARD PROGRAM THER EUT SCI |
6 | 0.0000139875 | PHARMACOEPIGENETICS//ALFRED MED EDUC PROJECT//BANDUNG HOSP |
7 | 0.0000085291 | MIR 155//MIR 146A//MIRNA 155 |
8 | 0.0000084562 | MICRORNA//MIR 21//MICRORNAS |
9 | 0.0000083221 | MIR 210//MICRORNA 210//C19MC |
10 | 0.0000076342 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |